HIV
Monthly injections offer similar efficacy to daily pills in HIV phase 3 trials
March 8, 2019Medical Communications ATLAS, GSK, HIV, ViiV, flair, injectable
A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare and J&J subsidiary Jannsen, …
Gilead’s Biktarvy maintains HIV suppression for 48 weeks in children and adolescents
March 7, 2019Research and Development Biktarvy, Gilead, HIV, pharma
Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 …
Scottish biotech secures initial orders for HIV diagnosis kit from Indonesia, Moldova and Papua New Guinea
March 7, 2019Business Services, Medical Communications, Research and Development, Sales and Marketing Diagnostics, HIV, Indonesia, Moldova, Scotland, developing coutnries
A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics …
London man becomes second in world to be cured of HIV
March 5, 2019Manufacturing and Production Berlin Patient, CCR5, HIV, He Jiankui, London Patient
A man in Britain has become the second person in the world to be ‘cured’ of HIV, after receiving a …
Read the March 2019 issue of Pharmafocus online now!
February 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Drug pricing, HIV, Trump, WHO, brexit, depression, mental health, pharmacovigilance, rare disease
Just one month to go until Brexit here in the UK, and it’s still all to play for. After months …
Genetically modified twins may have been altered in a way that improves memory and cognition
February 22, 2019Medical Communications CCR5, HIV, cognitive enhancement, crispr, gene editing
The twins who were genetically modified using the gene editing tool CRISPR may have been changed in a way that …
Researchers develop new, more effective method for detection of HIV virus genomes
February 8, 2019Medical Communications, Research and Development HIV, University of Texas, pharma
A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …
HIV drug holds hope for Alzheimer’s after significantly reducing inflammation in mice
February 7, 2019Research and Development HIV, dementia, inflamation
Lamivudine, a generic drug for HIV, significantly reduces age-related inflammation and other signs of aging in mice, according to a …
Health Secretary pledges to end transmission of HIV in England by 2030
January 31, 2019Medical Communications, Research and Development 2030, AIDS, England, HIV, UN, health
Through better prevention, detection and treatment, Health Secretary Matt Hancock has pledged to end transmission of HIV in England by …
Global Fund seeks £11bn as progress slows in fight against malaria, TB and HIV
January 14, 2019Sales and Marketing Africa, Global Fund, HIV, TB, infectious diseases, malaria, tuberculosis
The Global Fund is seeking £11 billion worth of investment in an attempt to save 16 million lives in the …
Trump administration block NIH researchers from using foetal tissue, disrupting research to cure HIV
December 10, 2018Sales and Marketing HIV, Trump, US government, feotal tissue, mice, research
The Trump Administration has halted the acquisition of new human foetal tissue for use in experiments conducted by NIH researchers, …
Top Ten most popular articles on Pharmafile.com this week
November 30, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HIV, Immuno Biotech, NHS, Roche, autism, biosimilars, pharma, top ten
We’ve come to the end of November, and with only one month of the year left to go, the industry …
MSD chalks up two HIV drug approvals in Europe
November 30, 2018Medical Communications, Sales and Marketing Delstrigo, EU, Europe, HIV, MSD, Pifeltro, pharma
MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo …
UK is among the first to meet UN targets for HIV treatment and prevention, Public Health England says
November 29, 2018Medical Communications HIV, UK, pharma
The UK is among the first countries in the world to meet the HIV treatment targets set out by the …
Immuno Biotech owner promoting unlicensed ‘cure’ for cancer, autism and HIV to be sentenced next week
November 23, 2018Medical Communications Cancer, David Noakes, GcMAF, HIV, UKIP, autism
The owner of Guernsey-based biotech Immuno Biotech Ltd, David Noakes, will be sentenced this week after admitting to a number …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
